The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility-Reference-Cited by-同舟云学术

The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility

Published:2022-07 Issue:4 Volume:74 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

LEYH-BANNURAH Sami-Ramzi,WAGNER Christian,SCHUETTE Andreas,ADDALI Mustapha,LIAKOS Nikolaos,URBANOVA Katarina,MENDREK Mikolaj,OELKE Matthias,WITT Jorn H.

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2022N04A0437

Reference29 articles.

1. Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins

2. Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up

3. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy

4. Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison

5. Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins may increase the risk of being diagnosed with prostate cancer;Minerva Urology and Nephrology;2023-10

2. Urinary outcomes of new ultra-minimally invasive treatments for prostate cancers;Current Opinion in Urology;2023-08-22

3. MRI/real-time ultrasound image fusion guided high-intensity focused ultrasound: a prospective comparative and functional analysis of different ablative techniques;Minerva Urology and Nephrology;2023-03

4. Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials;Cancers;2023-02-16

5. Comment on: "The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility";Minerva Urology and Nephrology;2022-07